seed
Stage
2023
Founded
1
Investors
About
LYLA develops a radiopharmaceutical quality assurance device that assesses the safety and quality of radioactive isotopes used in targeted radionuclide cancer therapies, enabling faster and more reliable quality control through direct alpha radiation measurement.
Explore LYLA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.